Internal Medicine, Pulmonary Disease · Clermont, FL
NPI
1740208404
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3121 Citrus Tower Blvd
Clermont, FL, 34711
Phone (352) 404-5968
Groups this clinician bills Medicare through
Medicare paid, 2024
$392K
6,047 services
Medicare patients, 2024
1,473
Average age 76
Drug cost, 2024
$3.6M
7,645 prescriptions
Company payments, 2025
$11K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad S Jalloul was code 99213 (office e&m - established), 2,535 times for 1,248 patients. In total Ahmad S Jalloul billed 6,047 services in 24 codes, and Medicare paid $392K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,535 | 1,248 | $65.37 | $166K |
| 94680 Pulmonary Function Testing | Office | 631 | 624 | $39.57 | $25K |
| 94729 Pulmonary Function Testing | Office | 630 | 623 | $40.17 | $25K |
| 94060 Pulmonary Function Testing | Office | 630 | 623 | $28.20 | $18K |
| 94726 Pulmonary Function Testing | Office | 628 | 621 | $39.60 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 277 | 115 | $61.34 | $17K |
| 99204 Office E&M - New | Office | 204 | 204 | $114.78 | $23K |
| 99223 Hospital E&M - Initial | Facility | 117 | 106 | $134.67 | $16K |
| 99205 Office E&M - New | Office | 103 | 103 | $159.30 | $16K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 61 | 61 | $66.17 | $4,036 |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 35 | $92.00 | $4,784 |
| 95810 Sleep Study | Office | 50 | 49 | $461.05 | $23K |
| 95811 Sleep Study | Office | 43 | 40 | $483.48 | $21K |
| 99215 Office E&M - Established | Office | 19 | 19 | $140.25 | $2,665 |
| 31624 Bronchoscopy | Facility | 19 | 18 | $103.23 | $1,961 |
By year: 2022 $430K for 5,965 services; 2023 $415K for 5,961 services; 2024 $392K for 6,047 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad S Jalloul prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,703 prescriptions and refills. In total Ahmad S Jalloul wrote 7,645 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,703 | 2,351 | 719 | $41K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,251 | 1,840 | 354 | $1.2M |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 735 | 1,009 | 227 | $627K |
| Breo Ellipta Fluticasone/Vilanterol | 560 | 814 | 146 | $313K |
| Montelukast Sodium Generic | 529 | 1,246 | 184 | $5,382 |
| Prednisone Generic | 523 | 689 | 322 | $2,491 |
| Azithromycin Generic | 234 | 244 | 180 | $1,225 |
| Symbicort Budesonide/Formoterol Fumarate | 215 | 314 | 66 | $70K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 177 | 386 | 75 | $39K |
| Spiriva Respimat Tiotropium Bromide | 159 | 274 | 47 | $132K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 144 | 206 | 59 | $96K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 139 | 233 | 49 | $18K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 88 | 120 | 23 | $53K |
| Ventolin Hfa Albuterol Sulfate | 84 | 110 | 37 | $5,728 |
| Fluticasone Propionate Generic | 73 | 154 | 38 | $1,123 |
Brand drugs: 4,705 claims; generic drugs: 2,940 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad S Jalloul $11K ($11K in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $7,697.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $7,697 |
| GlaxoSmithKline, LLC. GSK | 23 | $525 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $269 |
| Genzyme Corporation SNY | 8 | $228 |
| United Therapeutics Corporation UTHR | 6 | $182 |
| Harmony Biosciences LLC HRMY | 5 | $162 |
| Insmed, Inc. INSM | 6 | $159 |
| Electromed, Inc. ELMD | 11 | $154 |
| Pulmonx Corporation LUNG | 6 | $148 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.